UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling

Oncogene, 2011-06, Vol.30 (24), p.2730-2740

2011

Volltextzugriff (PDF)

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience

BMC cancer, 2023-09, Vol.23 (1), p.1-907, Article 907

2023

Volltextzugriff (PDF)

Modeling and simulation of cancer immunoprevention vaccine

Bioinformatics, 2005-06, Vol.21 (12), p.2891-2897

2005

Volltextzugriff (PDF)

CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity

Oncogene, 2014-04, Vol.33 (15), p.1912-1921

2014

Volltextzugriff (PDF)

DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice

The Journal of immunology (1950), 2000-11, Vol.165 (9), p.5133-5142

2000

Volltextzugriff (PDF)

CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity

Oncogene, 2007-10, Vol.26 (46), p.6604-6618

2007

Volltextzugriff (PDF)

Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer

Annals of oncology, 2009-02, Vol.20 (2), p.213-226

2009

Volltextzugriff (PDF)

Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice

Cancer research (Chicago, Ill.), 1998-09, Vol.58 (18), p.4127-4131

1998

Volltextzugriff (PDF)

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

The Journal of experimental medicine, 2001-11, Vol.194 (9), p.1195-1206

2001

Volltextzugriff (PDF)

A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome

Human gene therapy, 2009-05, Vol.20 (5), p.453-464

2009

Volltextzugriff (PDF)

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer

Oncogene, 2017-03, Vol.36 (12), p.1721-1732

2017

Volltextzugriff (PDF)

Analysis of vaccine’s schedules using models

Cellular immunology, 2006-12, Vol.244 (2), p.137-140

2006

Volltextzugriff (PDF)

MODELING TUMOR IMMUNOLOGY

Mathematical models & methods in applied sciences, 2006-07, Vol.16 (supp01), p.1091-1124

2006

Volltextzugriff (PDF)

Gene transfer of a secretable form of IL‐15 in murine adenocarcinoma cells: Effects on tumorigenicity, metastatic potential and immune response

International journal of cancer, 2000-08, Vol.87 (4), p.574-581

2000

Volltextzugriff (PDF)

Insulin-like Growth Factor I Receptor-mediated circuit in Ewing's Sarcoma/Peripheral Neuroectodermal Tumor : A possible therapeutic target

Cancer research (Chicago, Ill.), 1996-10, Vol.56 (20), p.4570-4574

1996

Volltextzugriff (PDF)

Cytokine gene therapy: Hopes and pitfalls

Annals of oncology, 1999-03, Vol.10 (3), p.261-266

1999

Volltextzugriff (PDF)

Model Deconstruction of an Immunoprevention Vaccine

Advances in Natural Computation, 2006, p.350-353

2006

Volltextzugriff (PDF)

Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model

Clinical and experimental medicine, 2009-09, Vol.9 (3), p.199-205

2009

Volltextzugriff (PDF)

Immunoprevention of cancer : Is the time ripe?

Cancer research (Chicago, Ill.), 2000-05, Vol.60 (10), p.2571-2575

2000

Volltextzugriff (PDF)

An anti-apoptotic role for NGF receptors in human rhabdomyosarcoma

European journal of cancer (1990), 2001-09, Vol.37 (13), p.1719-1725

2001

Volltextzugriff (PDF)

Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice

Cancer research (Chicago, Ill.), 2000-01, Vol.60 (2), p.359-364

2000

Volltextzugriff (PDF)

Interleukin 12 gene therapy of MHC-negative murine melanoma metastases

Cancer research (Chicago, Ill.), 1998-03, Vol.58 (6), p.1225-1230

1998

Volltextzugriff (PDF)

Tumor Rejection and Immune Memory Elicited by Locally Released LEC Chemokine Are Associated with an Impressive Recruitment of APCs, Lymphocytes, and Granulocytes

The Journal of immunology (1950), 2000-03, Vol.164 (6), p.3200-3206

2000

Volltextzugriff (PDF)

CD99 engagement : An effective therapeutic strategy for Ewing tumors

Cancer research (Chicago, Ill.), 2000-09, Vol.60 (18), p.5134-5142

2000

Volltextzugriff (PDF)

Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER‐2/neu transgenic mice

International journal of cancer, 1998-09, Vol.77 (6), p.937-941

1998

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(155)

Publikationsform

Artikel
(180)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(121)
Life Sciences & Biomedicine
(118)
Animals
(102)
Mice
(97)
Biological And Medical Sciences
(84)
Oncology
(77)
Medical Sciences
(74)
Humans
(72)
Female
(61)
Tumors
(48)
Mice, Inbred Balb C
(47)
Tumor Cells, Cultured
(46)
Pharmacology. Drug Treatments
(33)
Antineoplastic Agents
(32)
Mice, Transgenic
(28)
Transfection
(28)
Mammary Neoplasms, Experimental - Immunology
(25)
Mammary Neoplasms, Experimental - Pathology
(23)
Immunology
(22)
Mice, Nude
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience

Modeling and simulation of cancer immunoprevention vaccine

CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity

DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice

CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity

Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer

Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice

A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome

Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer

Analysis of vaccine’s schedules using models

MODELING TUMOR IMMUNOLOGY

Gene transfer of a secretable form of IL‐15 in murine adenocarcinoma cells: Effects on tumorigenicity, metastatic potential and immune response

Insulin-like Growth Factor I Receptor-mediated circuit in Ewing's Sarcoma/Peripheral Neuroectodermal Tumor : A possible therapeutic target

Cytokine gene therapy: Hopes and pitfalls

Model Deconstruction of an Immunoprevention Vaccine

Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model

Immunoprevention of cancer : Is the time ripe?

An anti-apoptotic role for NGF receptors in human rhabdomyosarcoma

Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice

Interleukin 12 gene therapy of MHC-negative murine melanoma metastases

Tumor Rejection and Immune Memory Elicited by Locally Released LEC Chemokine Are Associated with an Impressive Recruitment of APCs, Lymphocytes, and Granulocytes

CD99 engagement : An effective therapeutic strategy for Ewing tumors

Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER‐2/neu transgenic mice

Suchergebnisse filtern